# Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access

> **NCT06386458** · NA · COMPLETED · sponsor: **Hangzhou NOYA MedTech Co. Ltm.** · enrollment: 177 (actual)

## Conditions studied

- Heart Diseases
- Atrial Fibrillation

## Interventions

- **DEVICE:** AThrough radiofrequency transseptal puncture system
- **DEVICE:** Traditional mechanical transseptal puncture needle

## Key facts

- **NCT ID:** NCT06386458
- **Lead sponsor:** Hangzhou NOYA MedTech Co. Ltm.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-08
- **Primary completion:** 2023-05-09
- **Final completion:** 2023-05-11
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06386458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06386458, "Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06386458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*